Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
<p><strong>Objective:</strong><br /> To assess the effect of anti-CD20 B-cell depletion with rituximab (RTX) on relapse rates in myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD).</p><br /> <p><strong>Methods:</strong><...
Main Authors: | Whittam, DH, Cobo-Calvo, A, Lopez-Chiriboga, AS, Leite, MI, Palace, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
Frequency of MOG-IgG in cerebrospinal fluid versus serum
by: Pace, S, et al.
Published: (2021) -
MOG-IgG1 antibodies in children
by: Waters, P, et al.
Published: (2018) -
Phenotypic Characteristics and Recurrence Factors of MOG-IgG Associated Disorders in Children
by: WANG Xin, ZHAO Ruibin, YANG Huafang, LIU Chong, LIU Tian, LU Cui, CHEN Didi
Published: (2023-06-01) -
A multicenter comparison of MOG-IgG cell-based assays
by: Waters, P, et al.
Published: (2019) -
Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder
by: Eun Bin Cho, et al.
Published: (2024-03-01)